Wellington Management Group
IBRX icon

Wellington Management Group’s ImmunityBio IBRX Stock Holding History

Wellington Management Group’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$969K Sell
110,684
-23,171
-17% -$175K ﹤0.01% 1750
2026
Q1 		$1.03M Buy
+133,855
New +$916K ﹤0.01% 1666

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group's IBRX Position: Q2 2026 in Review

Wellington Management Group reduced its ImmunityBio (IBRX) stake by 17% in Q2 2026, selling an estimated $175K and leaving 110,684 shares worth $969K. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

Wellington Management Group first reported a position in IBRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.03M in Q1 2026. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Wellington Management Group held 110,684 shares of ImmunityBio worth $969K as of Q2 2026.
  • Wellington Management Group sold 23,171 ImmunityBio shares in Q2 2026, an estimated $175K.
  • ImmunityBio made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1750 holding.
  • Wellington Management Group first reported a position in ImmunityBio in Q1 2026 and has held it in 2 quarters since.
  • Wellington Management Group's ImmunityBio position peaked at $1.03M in Q1 2026.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.